Detalles de la búsqueda
1.
Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study.
BMJ Open
; 12(3): e051378, 2022 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35318229
Resultados
1 -
1
de 1
1
Próxima >
>>